Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway

被引:51
作者
Liu, Hui [1 ]
Li, Xiuming [2 ]
Duan, Yu [1 ]
Xie, Jin-Bo [1 ]
Piao, Xiang-Lan [1 ]
机构
[1] Minzu Univ China, Sch Pharm, Ctr Translat Neurosci, Key Lab Ethnomed,Minist Educ, Beijing 100081, Peoples R China
[2] Chengde Med Univ, Dept Urol, Affiliated Hosp, Chengde 067000, Hebei, Peoples R China
关键词
Gypenosides; Network pharmacology; Renal cell carcinoma; Molecular docking; PI3K/Akt/mTOR pathway;
D O I
10.1016/j.jep.2021.113907
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Gynostemma pentaphyllum (Thunb.) Makino is a traditional medicine commonly used in China, East Asia and Southeast Asia. In clinic, it is mainly used for hyperlipidemia and antitumor. Its antitumor activity was first recorded in "Illustrated Catalogue of Plants". Gypenosides were the main active ingredients of G. pentaphyllum. The anticancer activity of gypenosides in vivo and in vitro had been widely reported. However, the mechanism of gypenosides in renal cell carcinoma (RCC) still unclear. Aim of the study: In this study, we tried to investigate the active constituents from G. pentaphyllum and potential mechanisms in RCC treatment through network pharmacology and in vitro experiments. Material/methods: Active compounds and their targets were evaluated and screened through TCMSP and Swiss Target Prediction database. Notably, nine preliminary screened components obtained from database were identified by LC-MS and LC-MS/MS. The targets associated with RCC were obtained from OMIM, TTD and GeneCards database. The PPI network and active component/target/pathway networks were constructed to identify the potential drug targets using String database and Cytoscape software. The functions and pathways of targets were analyzed through DAVID database. Finally, AutoDockTools 1.5.6 was used for molecular docking to assess the binding ability between compounds and targets. To support our prediction, we then explore the antitumor effect and mechanism of gypenosides by vitro experiments. CCK8 and flow cytometry were performed to evaluate cell death treated with gypenosides. Quantitative real-time PCR and Western blot were conducted to detect the changes of PI3K/AKT/mTOR signaling pathway. Results: Nine saponins and 68 targets have been screened. The hub targets covered PIK3CA, VEGFA, STAT3, JAK2, CCND1 and MAPK3. Enrichment analysis showed that the pathways mainly contained PI3K/Akt/mTOR, HIF-1, TNF, JAK-STAT and MAPK signaling pathways. Gypenosides extracted from G. pentaphyllum showed strong activity against 786-0 and Caki-1 cells, and cell apoptosis were detected through Annexin V/PI dual staining assay. RT-qPCR showed that gypenosides downregulated the levels of PIK3CA, Akt and mTOR in Caki-1 and 786-0 cells. Mechanistically, gypenosides induced apoptosis of RCC cells through regulating PI3K/Akt/mTOR signaling pathway which was implemented though decreasing the phosphorylation level of Akt and mTOR. Conclusions: Gypenosides induced apoptosis of RCC cells by modulating PI3K/Akt/mTOR signaling pathway.
引用
收藏
页数:11
相关论文
共 39 条
  • [1] Natural gypenosides: targeting cancer through different molecular pathways
    Ahmad, Bashir
    Khan, Suliman
    Nabi, Ghulam
    Gamallat, Yaser
    Su, Pengyu
    Jamalat, Yazeed
    Duan, Pengfei
    Yao, Lunguang
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2287 - 2297
  • [2] Treatment of renal cell carcinoma: Current status and future directions
    Barata, Pedro C.
    Rini, Brian I.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) : 507 - 524
  • [3] Rapamycin passes the torch: a new generation of mTOR inhibitors
    Benjamin, Don
    Colombi, Marco
    Moroni, Christoph
    Hall, Michael N.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (11) : 868 - 880
  • [4] Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines
    Bodnar, L.
    Stec, R.
    Cierniak, S.
    Synowiec, A.
    Wcislo, G.
    Jesiotr, M.
    Koktysz, R.
    Kozlowski, W.
    Szczylik, C.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (07) : 1385 - 1389
  • [5] Saikosaponin-d suppresses cell growth in renal cell carcinoma through EGFR/p38 signaling pathway
    Cai, C.
    Zhang, H.
    Ou, Y.
    Jiang, Y.
    Zhong, D.
    Qi, H.
    Dang, Q.
    [J]. NEOPLASMA, 2017, 64 (04) : 518 - 525
  • [6] From single drug targets to synergistic network pharmacology in ischemic stroke
    Casas, Ana I.
    Hassan, Ahmed A.
    Larsen, Simon J.
    Gomez-Rangel, Vanessa
    Elbatreek, Mahmoud
    Kleikers, Pamela W. M.
    Guney, Emre
    Egea, Javier
    Lopez, Manuela G.
    Baumbach, Jan
    Schmidt, Harald H. H. W.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (14) : 7129 - 7136
  • [7] Timosaponin AIII inhibits metastasis of renal carcinoma cells through suppressing cathepsin C expression by AKT/miR-129-5p axis
    Chiang, Kuang-Chung
    Lai, Chung-Yu
    Chiou, Hui-Ling
    Lin, Chia-Liang
    Chen, Yong-Syuan
    Kao, Shao-Hsuan
    Hsieh, Yi-Hsien
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 13332 - 13341
  • [8] Two Phase 2 Trials of the Novel Akt Inhibitor Perifosine in Patients With Advanced Renal Cell Carcinoma After Progression on Vascular Endothelial Growth Factor-Targeted Therapy
    Cho, Daniel C.
    Hutson, Thomas E.
    Samlowski, Wolfram
    Sportelli, Peter
    Somer, Brad
    Richards, Paul
    Sosman, Jeffrey A.
    Puzanov, Igor
    Michaelson, M. Dror
    Flaherty, Keith T.
    Figlin, Robert A.
    Vogelzang, Nicholas J.
    [J]. CANCER, 2012, 118 (24) : 6055 - 6062
  • [9] Neuroprotective Effects of Herbal Ethanol Extracts from Gynostemma pentaphyllum in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease
    Choi, Hyun Sook
    Park, Mi Sook
    Kim, Seung Hwan
    Hwang, Bang Yeon
    Lee, Chong Kil
    Lee, Myung Koo
    [J]. MOLECULES, 2010, 15 (04): : 2814 - 2824
  • [10] The PI3K/AKT Pathway and Renal Cell Carcinoma
    Guo, Huifang
    German, Peter
    Bai, Shanshan
    Barnes, Sean
    Guo, Wei
    Qi, Xiangjie
    Lou, Hongxiang
    Liang, Jiyong
    Jonasch, Eric
    Mills, Gordon B.
    Ding, Zhiyong
    [J]. JOURNAL OF GENETICS AND GENOMICS, 2015, 42 (07) : 343 - 353